These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18055860)

  • 21. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
    Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme.
    Nakagawa K; Aoki Y; Fujimaki T; Tago M; Terahara A; Karasawa K; Sakata K; Sasaki Y; Matsutani M; Akanuma A
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1141-9. PubMed ID: 9539570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofractionated conformal irradiation of patients with malignant glioma.
    Aboziada MA; Abo-Kresha AE
    J Egypt Natl Canc Inst; 2012 Sep; 24(3):139-43. PubMed ID: 22929920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.
    Chang EL; Akyurek S; Avalos T; Rebueno N; Spicer C; Garcia J; Famiglietti R; Allen PK; Chao KS; Mahajan A; Woo SY; Maor MH
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):144-50. PubMed ID: 17306935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in 3-dimensional conformal radiotherapy for glioblastoma multiforme].
    Yue JB; Yu JM; Sun XD
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):641-3. PubMed ID: 18246789
    [No Abstract]   [Full Text] [Related]  

  • 29. Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.
    Fariselli L; Pinzi V; Milanesi I; Silvani A; Marchetti M; Farinotti M; Salmaggi A
    Strahlenther Onkol; 2013 Jun; 189(6):456-61. PubMed ID: 23625362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformal radiation therapy with fixed shaped coplanar or noncoplanar radiation beam bouquets: a possible alternative to radiosurgery.
    Marks LB; Sherouse GW; Das S; Bentel GC; Spencer DP; Turner D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1209-19. PubMed ID: 7493845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
    Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lakomý R; Lojová M; Souckova L; Hynkova L; Polachova K; Vasina J; Demlová R; Poprach A; Sana J; Prochazka T; Smrcka M; Fadrus P; Jancalek R; Selingerova I; Belanova R; Slampa P; Pospisil P; Kazda T
    BMC Cancer; 2024 Jun; 24(1):736. PubMed ID: 38879476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme.
    Chen YD; Feng J; Fang T; Yang M; Qiu XG; Jiang T
    Chin Med J (Engl); 2013 Jun; 126(12):2320-4. PubMed ID: 23786946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
    Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
    Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
    Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.
    Mizumoto M; Yamamoto T; Takano S; Ishikawa E; Matsumura A; Ishikawa H; Okumura T; Sakurai H; Miyatake S; Tsuboi K
    Pract Radiat Oncol; 2015; 5(1):e9-16. PubMed ID: 25413424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.